Danazol treatment of endometriosis: long-term follow-up. 1979

R B Greenblatt, and V Tzingounis

Forty-nine women diagnosed as having pelvic endometriosis were treated with 800 mg of danazol/day for a mean duration of 6 months. The average length of the follow-up period was 78 months. Side effects were minimal, and regular ovulatory menses returned within 25 to 90 days (average 42 days). Forty-two (85.7% of these women had associated infertility. Recurrence of symptoms was reported in 33% but in no patient were the symptoms worse than before entering the study. Of 30 patients desirous of pregnancy, 20 were potentially fertile; of these, 10 conceived within 6 months of discontinuing therapy, for a conception rate of 50%. Nine of the remaining ten patients required additional therapeutic procedures (surgery and/or danazol), and four of these conceived within 12 months. These results compare favorably with those of other investigations, since most of our patients were referred to us after being subjected to a variety of regimens, both hormonal and surgical.

UI MeSH Term Description Entries
D011245 Pregnadienes Pregnane derivatives containing two double bonds anywhere within the ring structures.
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D003613 Danazol A synthetic steroid with antigonadotropic and anti-estrogenic activities that acts as an anterior pituitary suppressant by inhibiting the pituitary output of gonadotropins. It possesses some androgenic properties. Danazol has been used in the treatment of endometriosis and some benign breast disorders. Azol,Cyclomen,Danatrol,Danazant,Danazol-Ratiopharm,Danocrine,Danol,Danoval,Ladogal,Norciden,Panacrine,Danazol Ratiopharm
D004715 Endometriosis A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum. Endometrioma,Endometriomas,Endometrioses
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R B Greenblatt, and V Tzingounis
January 1977, The Journal of international medical research,
R B Greenblatt, and V Tzingounis
March 2021, BMC women's health,
R B Greenblatt, and V Tzingounis
January 1979, Postgraduate medical journal,
R B Greenblatt, and V Tzingounis
January 2022, American journal of obstetrics and gynecology,
R B Greenblatt, and V Tzingounis
December 2000, The journal of obstetrics and gynaecology research,
R B Greenblatt, and V Tzingounis
March 1993, Fertility and sterility,
R B Greenblatt, and V Tzingounis
January 1984, Acta obstetricia et gynecologica Scandinavica. Supplement,
R B Greenblatt, and V Tzingounis
April 2004, American journal of obstetrics and gynecology,
R B Greenblatt, and V Tzingounis
June 2005, Fertility and sterility,
Copied contents to your clipboard!